Mobile Menu - OpenMobile Menu - Closed

Health

Committee activity related to implementation of the Affordable Care Act; health insurance company practices; Medicare and Medicaid; prescription drugs; chronic and infectious diseases; reproductive and women’s health; and the safety of America’s food supply. 

More on Health

May 22, 2019 Hearing

The Full Committee will hold a hearing on the bill on Wednesday, May 22, at 10 am in the John D. Dingell Room, 2123 Rayburn House Office Building. The hearing is entitled, “LIFT America: Modernizing Our Infrastructure for the Future.”

 

May 21, 2019 Hearing

The Health Subcommittee will hold a legislative hearing on Tuesday, May 21, at 10:30 am in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, “Improving Drug Pricing Transparency and Lowering Prices for American Consumers."

 

May 16, 2019 Press Release
Chairman Pallone's floor remarks on H.R. 987
May 15, 2019 Press Release
Chairman Pallone and all 31 Democratic members of the Energy and Commerce Committee announce the introduction of LIFT America, a comprehensive infrastructure package aimed at combating the climate crisis, expanding broadband internet access and protecting public health. A full committee hearing on LIFT America will be held on Wednesday, May 22 at 10 AM.
May 14, 2019 Press Release
House Committee Chairmen sent letters to the Trump Administration reiterating their demand for information on the decision not to defend the Affordable Care Act.
May 14, 2019 Press Release
The Health Subcommittee will hold a legislative hearing on drug supply chain transparency proposals.
May 13, 2019 Press Release
Chairman Pallone's statement on a lawsuit from 44 states alleging drug companies conspired to fix prescription drug prices.
May 9, 2019 Press Release
Chairman Pallone's floor remarks in support of H.R. 986
May 9, 2019 Press Release
Bipartisan Committee leaders' statement committing to addressing surprise billing.
May 9, 2019 Press Release
Chairman Pallone's opening remarks at a hearing on the prescription drug supply chain.